16 completed, 7 recruiting, 5 active not recruiting, 5 unknown. 24 Phase 2, 6 Early Phase 1, 6 Phase 1, 5 Not applicable, 3 Phase 3.
Follow 68Ga-PSMA: new trials by email Literature Review of 68Ga-PSMA trials Research Report on 68Ga-PSMA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate Cancer Biospecimen Collection, Computed Tomography, Gallium Ga 68 Gozetotide - Metastatic Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 1 | Not yet recruiting | University of Michigan Rogel Cancer Center | 20 | 2026-12-01 | 2026-10-15 |
| An Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or Progression in Patients With Glioma Computed Tomography, Electronic Health Record Review, Ga 68 PSMA-11 - WHO Grade 3 Glioma, WHO Grade 4 Glioma | Phase 2 | Recruiting | Mayo Clinic | 25 | 2026-01-12 | 2026-06-22 |
| Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for the Treatment of Recurrent, Oligometastatic Prostate Adenocarcinoma Actinium Ac 225 Vipivotide Tetraxetan, Biospecimen Collection, Gallium Ga 68 Gozetotide - Oligometastatic Prostate Adenocarcinoma, Recurrent Prostate Adenocarcinoma | Phase 2 | Recruiting | Jonsson Comprehensive Cancer Center | 107 | 2025-12-12 | 2026-09-17 |
| Preoperative Planning With PSMA-PET in Melanoma Surgery Trial 68Ga-PSMA - Malignant Melanoma | Phase 2 | Recruiting | Royal Marsden NHS Foundation Trust | 16 | 2025-03-11 | 2025-07-01 |
| Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer Biopsy Procedure, Biospecimen Collection, Bone Scan - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma | Phase 2 | Recruiting | Fred Hutchinson Cancer Center | 15 | 2024-09-18 | 2026-08-06 |
| An Investigational Scan (Ga-68 PSMA-11 PET/CT) for the Detection of Therapy Response in Patients With Metastatic Adenoid Cystic Carcinoma Computed Tomography, Electronic Health Record Review, Ga-68 PSMA-11 - Metastatic Adenoid Cystic Carcinoma | Phase 2 | Completed | Mayo Clinic | 6 | 2024-08-12 | 2025-09-12 |
| Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial Biospecimen Collection, Computed Tomography, Gallium Ga 68 Gozetotide - Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 2 | Recruiting | Jonsson Comprehensive Cancer Center | 40 | 2024-08-01 | 2026-03-13 |
| Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) Computed Tomography, Gallium Ga 68 Gozetotide, Lutetium Lu 177 Vipivotide Tetraxetan - Prostate Carcinoma, Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8 | Phase 2 | Recruiting | Jonsson Comprehensive Cancer Center | 90 | 2024-08-01 | 2026-03-10 |
| Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer Biospecimen Collection, Bone Scan, Clinical Observation - Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 2 | Suspended | Mayo Clinic | 236 | 2024-05-03 | 2026-08-20 |
| Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial Apalutamide, Biospecimen Collection, Computed Tomography - Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8 | Phase 2 | Recruiting | Jonsson Comprehensive Cancer Center | 95 | 2024-03-28 | 2026-07-17 |
| Gallium-68 PSMA-11 PET in Participants With Prostate Cancer Computed Tomography, Gallium Ga 68-labeled PSMA-11, Magnetic Resonance Imaging - Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma | Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2022-09-26 | 2024-03-07 | |
| 68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer Computed Tomography, Gallium Ga 68 Gozetotide, Positron Emission Tomography - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 3 | Completed | Mayo Clinic | 163 | 2022-05-09 | 2025-07-18 |
| Clinical Applications of Integrated PET/MR and PET/CT in the Diagnosis and Treatment of Prostate Cancer. 68Ga-PSMA - Prostate Cancer, Pet-ct | Not applicable | Suspended | The First Affiliated Hospital of Anhui Medical University | 50 | 2022-04-28 | 2024-04-09 |
| Comparison of Hepatic Intraarterial Versus Systemic Intravenous 68Ga-PSMA PET/CT for Detection of Hepatocellular Carcinoma Gallium Ga 68 Gozetotide, Hepatic Artery Embolization, Positron Emission Tomography and Computed Tomography Scan - Hepatocellular Carcinoma | Early Phase 1 | Withdrawn | Mayo Clinic | 2022-02-11 | 2023-11-07 | |
| 68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer Computed Tomography, Gallium Ga 68 Gozetotide, Positron Emission Tomography - Advanced Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8 | Phase 2 | Completed | Mayo Clinic | 26 | 2022-01-30 | 2026-09-29 |
| Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy Biopsy of Prostate, Gallium Ga 68 Gozetotide, Transrectal Ultrasonography Guided Biopsy - Prostate Carcinoma | Early Phase 1 | Active not recruiting | Jonsson Comprehensive Cancer Center | 30 | 2022-01-13 | 2026-02-12 |
| Diagnosis of Renal Cell Carcinoma on 68Ga-PSMA PET-CT and Radioligand Therapy With 177Lu-EB-PSMA-617 68Ga-PSMA, 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617 - Renal Cell Carcinoma | Not applicable | Unknown | Peking Union Medical College Hospital | 40 | 2021-12-01 | 2021-12-28 |
| Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular Carcinoma 68Ga-PSMA, PET/MR, PET/CT - Malignant Neoplasm | Not applicable | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 30 | 2021-08-16 | 2023-02-14 |
| Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer Computed Tomography, Fluciclovine F18, Gallium Ga 68 Gozetotide - Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Lobular Carcinoma | Phase 1 | Completed | Emory University | 20 | 2021-07-16 | 2025-01-17 |
| 68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy Computed Tomography, Gallium Ga 68 Gozetotide, Positron Emission Tomography - Biochemically Recurrent Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone | Phase 2 | Terminated | Jonsson Comprehensive Cancer Center | 22 | 2021-06-16 | 2022-10-21 |
Showing 20 of 42. Sign in to see all of them.
Prostatic Neoplasms (26) · Carcinoma, Hepatocellular (4) · Carcinoma, Adenoid Cystic (2) · Carcinoma, Renal Cell (2) · Breast Neoplasms (1) · Carcinoma, Lobular (1) · Colonic Neoplasms (1) · Esophageal Neoplasms (1) · Lung Neoplasms (1) · Melanoma (1) · Neoplasms (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Stomach Neoplasms (1)
Jonsson Comprehensive Cancer Center (13) · Mayo Clinic (8) · Emory University (2) · IRCCS San Raffaele (2) · Peking Union Medical College Hospital (2) · University of Michigan Rogel Cancer Center (2) · City of Hope Medical Center (1) · Ebrahim Delpassand (1) · Fred Hutchinson Cancer Center (1) · German Cancer Research Center (1) · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS (1) · Jules Bordet Institute (1) · M.D. Anderson Cancer Center (1) · Royal Marsden NHS Foundation Trust (1) · The First Affiliated Hospital of Anhui Medical University (1)
United States (31) · China (4) · Italy (3) · Austria (1) · Germany (1) · United Kingdom (1)
Jeremie Calais (5) · Jeremie Calais, MD (3) · Ajit H. Goenka, M.D. (2) · Amar Kishan (2) · Brian J. Burkett, MD, MPH (2) · Morand R Piert, M.D. (2) · Zhaohui Zhu, MD (2) · Ashesh Jani, MD, MSEE (1) · Brian Miles, MD (1) · Carlos Artigas, MD (1) · David M Schuster, MD (1) · Delphine L. Chen, M.D. (1) · Frederik Giesel, Prof. Dr. (1) · Geoffrey B. Johnson, M.D., Ph.D. (1) · Gregory C Ravizzini, MD (1)
PMID 41698328, PMID 33602654, PMID 1289676, PMID 15493005, PMID 18207194, PMID 18325358, PMID 21149473, PMID 22369515, PMID 23041906, PMID 24072344, PMID 24207135, PMID 25598074, PMID 25883127, PMID 26116124, PMID 26294298, PMID 26334122, PMID 26361169, PMID 26681984, PMID 27609792, PMID 28267452, PMID 29129779, PMID 29242398, PMID 29242404, PMID 29786490, PMID 30616601, PMID 30920593, PMID 31375469, PMID 32808077, PMID 32958451, PMID 33386288, PMID 34326126, PMID 34529005, PMID 34649942, PMID 34783177, PMID 35984529, PMID 35985901, PMID 36512649, PMID 37482512, PMID 37902861, PMID 38976035, PMID 39420060, PMID 39570398, PMID 40876952, PMID 41101974, PMID 41679923, PMID 42377125
P30CA138292 (2), P30CA033572 (1), R01CA226992 (1), R01CA289631 (1), R37CA286450 (1)